Dysregulated miRNAs in recurrent miscarriage: A systematic review
•Recurrent Miscarriage is an unpleasant reproductive condition in females.•miRNAs are short sequences of non-coding RNAs with regulatory properties.•Finding suggests the possible correlation between miRNAs levels and miscarriage.•Using different mechanism miRNAs can affect the occurrence of miscarri...
Gespeichert in:
Veröffentlicht in: | Gene 2023-10, Vol.884, p.147689-147689, Article 147689 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Recurrent Miscarriage is an unpleasant reproductive condition in females.•miRNAs are short sequences of non-coding RNAs with regulatory properties.•Finding suggests the possible correlation between miRNAs levels and miscarriage.•Using different mechanism miRNAs can affect the occurrence of miscarriage.
Recurrent miscarriage (RM) is a complex reproductive medicine disease that affects many families. The cause of RM is unclear at this time; however, lifestyle and genetic variables may influence the process. The slight alteration in miRNA expression has enormous consequences for a variety of difficulties, one of which may be RM. The target of this systematic study was to provide a framework of the dysregulated miRNAs in RM. The Prisma guidelines were applied to perform current systematic review pertaining to articles in the seven databases. Thirty-nine papers out of 245 received fulfilled all inclusion requirements. From all the mentioned miRNAs, 40 were up-regulated (65.57 %), whereas 21 were down-regulated (34.43 %). These dysregulated miRNAs contributed to the pathophysiology of RM by influencing key pathways and processes such as apoptosis, angiogenesis, epithelial-mesenchymal transition, and the immune system. Understanding the dysregulation of miRNAs, as well as the pathways and processes that engage these miRNAs and impact disease pathogenesis, may aid in clarifying the unknown underlying mechanisms of RM and the development of novel molecular therapeutic targets and medical domains. |
---|---|
ISSN: | 0378-1119 1879-0038 |
DOI: | 10.1016/j.gene.2023.147689 |